CNBC 快讯 7月1日 10:12 新药数据推动 Jefferies 将这只法国 biotech 评级上调至买入 New drug data makes this French biotech stock a buy, says Jefferies Analyst Faisal Khurshid upgraded the stock to buy from hold. FG 100 读报告 →